BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 19903340)

  • 1. PTEN inhibits BMI1 function independently of its phosphatase activity.
    Fan C; He L; Kapoor A; Rybak AP; De Melo J; Cutz JC; Tang D
    Mol Cancer; 2009 Nov; 8():98. PubMed ID: 19903340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bmi1 promotes prostate tumorigenesis via inhibiting p16(INK4A) and p14(ARF) expression.
    Fan C; He L; Kapoor A; Gillis A; Rybak AP; Cutz JC; Tang D
    Biochim Biophys Acta; 2008 Nov; 1782(11):642-8. PubMed ID: 18817867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Akt-mediated phosphorylation of Bmi1 modulates its oncogenic potential, E3 ligase activity, and DNA damage repair activity in mouse prostate cancer.
    Nacerddine K; Beaudry JB; Ginjala V; Westerman B; Mattiroli F; Song JY; van der Poel H; Ponz OB; Pritchard C; Cornelissen-Steijger P; Zevenhoven J; Tanger E; Sixma TK; Ganesan S; van Lohuizen M
    J Clin Invest; 2012 May; 122(5):1920-32. PubMed ID: 22505453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells.
    Song LB; Li J; Liao WT; Feng Y; Yu CP; Hu LJ; Kong QL; Xu LH; Zhang X; Liu WL; Li MZ; Zhang L; Kang TB; Fu LW; Huang WL; Xia YF; Tsao SW; Li M; Band V; Band H; Shi QH; Zeng YX; Zeng MS
    J Clin Invest; 2009 Dec; 119(12):3626-36. PubMed ID: 19884659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BMI1 promotes cardiac fibrosis in ischemia-induced heart failure via the PTEN-PI3K/Akt-mTOR signaling pathway.
    Yang W; Wu Z; Yang K; Han Y; Chen Y; Zhao W; Huang F; Jin Y; Jin W
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H61-H69. PubMed ID: 30359076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTEN lipid phosphatase activity and proper subcellular localization are necessary and sufficient for down-regulating AKT phosphorylation in the nucleus in Cowden syndrome.
    He X; Saji M; Radhakrishnan D; Romigh T; Ngeow J; Yu Q; Wang Y; Ringel MD; Eng C
    J Clin Endocrinol Metab; 2012 Nov; 97(11):E2179-87. PubMed ID: 22962422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KDM5B Is Essential for the Hyperactivation of PI3K/AKT Signaling in Prostate Tumorigenesis.
    Li G; Kanagasabai T; Lu W; Zou MR; Zhang SM; Celada SI; Izban MG; Liu Q; Lu T; Ballard BR; Zhou X; Adunyah SE; Matusik RJ; Yan Q; Chen Z
    Cancer Res; 2020 Nov; 80(21):4633-4643. PubMed ID: 32868382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol regulates PTEN/Akt pathway through inhibition of MTA1/HDAC unit of the NuRD complex in prostate cancer.
    Dhar S; Kumar A; Li K; Tzivion G; Levenson AS
    Biochim Biophys Acta; 2015 Feb; 1853(2):265-75. PubMed ID: 25447541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades.
    Lu Y; Yu Q; Liu JH; Zhang J; Wang H; Koul D; McMurray JS; Fang X; Yung WK; Siminovitch KA; Mills GB
    J Biol Chem; 2003 Oct; 278(41):40057-66. PubMed ID: 12869565
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Lu XX; Cao LY; Chen X; Xiao J; Zou Y; Chen Q
    Biomed Res Int; 2016; 2016():2476842. PubMed ID: 27822469
    [No Abstract]   [Full Text] [Related]  

  • 11. Akt phosphorylates the transcriptional repressor bmi1 to block its effects on the tumor-suppressing ink4a-arf locus.
    Liu Y; Liu F; Yu H; Zhao X; Sashida G; Deblasio A; Harr M; She QB; Chen Z; Lin HK; Di Giandomenico S; Elf SE; Yang Y; Miyata Y; Huang G; Menendez S; Mellinghoff IK; Rosen N; Pandolfi PP; Hedvat CV; Nimer SD
    Sci Signal; 2012 Oct; 5(247):ra77. PubMed ID: 23092893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN blocks insulin-mediated ETS-2 phosphorylation through MAP kinase, independently of the phosphoinositide 3-kinase pathway.
    Weng LP; Brown JL; Baker KM; Ostrowski MC; Eng C
    Hum Mol Genet; 2002 Jul; 11(15):1687-96. PubMed ID: 12095911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K/AKT/mTOR axis.
    Tan M; Xu J; Siddiqui J; Feng F; Sun Y
    Mol Cancer; 2016 Dec; 15(1):81. PubMed ID: 27955654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-existence of high levels of the PTEN protein with enhanced Akt activation in renal cell carcinoma.
    He L; Fan C; Gillis A; Feng X; Sanatani M; Hotte S; Kapoor A; Tang D
    Biochim Biophys Acta; 2007 Oct; 1772(10):1134-42. PubMed ID: 17681738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bmi1 functions as an oncogene independent of Ink4A/Arf repression in hepatic carcinogenesis.
    Xu CR; Lee S; Ho C; Bommi P; Huang SA; Cheung ST; Dimri GP; Chen X
    Mol Cancer Res; 2009 Dec; 7(12):1937-45. PubMed ID: 19934271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration.
    Dey N; Crosswell HE; De P; Parsons R; Peng Q; Su JD; Durden DL
    Cancer Res; 2008 Mar; 68(6):1862-71. PubMed ID: 18339867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clusterin enhances AKT2-mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuit.
    Bertacchini J; Mediani L; Beretti F; Guida M; Ghalali A; Brugnoli F; Bertagnolo V; Petricoin E; Poti F; Arioli J; Anselmi L; Bari A; McCubrey J; Martelli AM; Cocco L; Capitani S; Marmiroli S
    J Cell Physiol; 2019 Jul; 234(7):11188-11199. PubMed ID: 30565691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear PTEN-mediated growth suppression is independent of Akt down-regulation.
    Liu JL; Sheng X; Hortobagyi ZK; Mao Z; Gallick GE; Yung WK
    Mol Cell Biol; 2005 Jul; 25(14):6211-24. PubMed ID: 15988030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-beta by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2.
    Song K; Cornelius SC; Reiss M; Danielpour D
    J Biol Chem; 2003 Oct; 278(40):38342-51. PubMed ID: 12876289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential role of PTEN in transforming growth factor β (TGF-β) effects on proliferation and migration in prostate cancer cells.
    Kimbrough-Allah MN; Millena AC; Khan SA
    Prostate; 2018 Apr; 78(5):377-389. PubMed ID: 29341212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.